The latest price target for BrightSpring Health (NASDAQ:BTSG) was reported by UBS on November 4, 2024. The analyst firm set a price target for $22.00 expecting BTSG to rise to within 12 months (a possible 12.88% upside). 19 analyst firms have reported ratings in the last year.

The latest analyst rating for BrightSpring Health (NASDAQ:BTSG) was provided by UBS, and BrightSpring Health maintained their buy rating.

There is no last upgrade for BrightSpring Health

There is no last downgrade for BrightSpring Health.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BrightSpring Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BrightSpring Health was filed on November 4, 2024 so you should expect the next rating to be made available sometime around November 4, 2025.

While ratings are subjective and will change, the latest BrightSpring Health (BTSG) rating was a maintained with a price target of $20.00 to $22.00. The current price BrightSpring Health (BTSG) is trading at is $19.49, which is out of the analyst’s predicted range.